What Biosimilar Developers Need to Know?

The Central Drugs Standard Control Organization (CDSCO) has released its 2025 draft revision of the "Guidelines on Similar Biologics" for marketing authorization in India. This update brings India's biosimilar regulatory…

Continue Reading

Future of Biosimilar Assay Customization

In the rapidly evolving landscape of biologics, biosimilars are taking center stage. As the global demand for affordable & effective therapeutic solutions rises, biosimilar development has become a focal point…

Continue Reading

How to find the Perfect R&D Partner?

POV: you are a biotech innovator with a breakthrough biologic or diagnostic platform. Building your own R&D infrastructure from hires, labs and certifications can cost $2–5 million and take 18–24…

Continue Reading

The Role of Cryopreservation in Biopharma

Introduction At a staggering -196°C, cryopreservation is more than just a freezing technique, it is the backbone of long-term biological research and therapeutic development. As biotech and pharmaceutical industries evolve…

Continue Reading

The Biotech Buyer’s Guide

A smart checklist for CROs, Biopharma & Diagnostics The biotechnology procurement landscape is rapidly evolving with a greater focus on quality, compliance and speed to market. If you are a CRO,…

Continue Reading

Lateral Flow Assay Development

A rapid diagnostic platform powering R&D and Biopharma In the fast-evolving landscape of life sciences and biopharma, the need for rapid, reliable and user-friendly diagnostic tools has never been greater.…

Continue Reading

Power of CHO in Biopharma Manufacturing

Chinese Hamster Ovary (CHO) cells have been the backbone of biopharmaceutical production for decades, enabling the development of life-saving monoclonal antibodies, vaccines, and recombinant proteins. As we go through 2025,…

Continue Reading

Tackling CHO Contamination Risks

Advanced HCP Detection for Safer Therapeutics In the high-stakes scene of biopharmaceutical development, even a single contamination event can derail years of progress, compromise patient safety, and incur staggering financial…

Continue Reading

CHO Host Cell Protein (HCP) Analysis

Designing Custom Assays for Biopharma In the complex world of biopharmaceutical development, the stakes are high. Every therapeutic protein, monoclonal antibody, or vaccine must meet stringent safety and efficacy standards.…

Continue Reading

End of content

No more pages to load

Close Navigation